Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 719 results for "continuous renal replacement therapy"

Continuous Renal Replacement Therapy Market Value Share, Analysis and Segments 2016-2026
MyNewsDesk

Give your dog an 'artificial kidney' for a night

Continuous renal replacement therapy, a procedure that involves both dialysis and blood transfusion, takes 10 hours CHENNAI: If your dog is suffering from weak kidneys, fret not. Here's a way to turn your pet from near comatose to cheery ... New Indian Express, 2 days ago
[x]  

9 images for continuous renal replacement therapy

MyNewsDesk, 1 month ago
MyNewsDesk, 3 months ago
Renal & Urology News, 4 days ago
Critical Care, 1 month ago
Critical Care, 1 month ago
Medagadget.com, 5 months ago
Medagadget.com, 5 months ago
Medical News Today, 4 months ago
First Post.com, 5 months ago
Free Malaysia Today

Thai palace: King's kidneys still not functioning properly

BANGKOK An announcement Wednesday night said the king is receiving continuous renal replacement therapy, a treatment for critically ill patients with acute kidney failure. It said Bhumibol is still producing insufficient urine. The medical ...
 FOXNews.com3 weeks ago Thailand's king recovers after treatment for water in lungs  Free Malaysia Today4 weeks ago King's kidneys still not functioning properly  Business Mirror2 weeks ago HM the King treated for water on lungs, better  News EasyBranches.com3 weeks ago
[x]  
NephrologyNews.com

Cancer screening and treatment in patients with end-stage renal disease: remaining issues in the field of onco-nephrology

Kitai et al. Renal Replacement Therapy Cancer screening and treatment in patients with end-stage renal disease: remaining issues in the field of onco-nephrology Yuichiro Kitai 0 Takeshi Matsubara 0 Taro Funakoshi 1 Takahiro Horimatsu 1 Manabu Muto 1 ...
 Paperity1 month ago Developing new tools to treat renal care  NephrologyNews.com2 weeks ago Criteria for and Appropriateness of Renal Transplantation in Elderly Patients With End-Stage Renal Disease: A Literature Review and Position Statement on Behalf of the European Renal Association-European Dialysis and Transplant Association Descartes Work  Transplantation1 week ago
PharmaVOICE

CORRECTING and REPLACING Xcell Biosciences Initiates New Collaborations with UCSF Researchers Studying Effectiveness of Immunotherapy in Urologic Cancers

Please replace the release with the following corrected version due to multiple revisions. The corrected release reads: XCELL BIOSCIENCES INITIATES NEW COLLABORATIONS WITH UCSF RESEARCHERS STUDYING EFFECTIVENESS OF IMMUNOTHERAPY IN UROLOGIC ...
 Sys-Con Belgium1 week ago Xcell Biosciences Initiates New Collaborations with UCSF Researchers Studying Effectiveness of Immunotherapy in Urologic Cancers  PharmaVOICE1 week ago
[x]  

B. Braun Renal Therapies Division to Launch New Class of Kidney Dialyzer

- The Renal Therapies Division of B. Braun Medical Inc., announced today that it will launch xevonta, a next generation dialyzer for the U.S. market, after recently receiving 510(k) clearance. A dialyzer is a dialysis filter and is often referred ...
 Yahoo! Singapore4 weeks ago B. Braun Medical Renal Therapies Division To Launch New Class Of Kidney Dialyzer  BioSpace4 weeks ago
[x]  

Percutaneous Mitral Valve Replacement

An overview of the transcatheter valve replacement therapies for treating mitral regurgitation. By Ander Regueiro, MD, and Josep Rod├ęs-Cabau, MD M itral regurgitation (MR) is the most common form of valvular heart disease, particularly in ...
 Cardiac Interventions Today1 month ago

Bharat Book Bureau: Renal Disease Treatments: Products and Therapies

The U.S. market for kidney failure treatment will grow from $39.4 billion in 2016 to nearly $45.6 billion by 2021, with a compound annual growth rate (CAGR) of 3.0% for the period of 2016-2021. This report provides: -An in-depth analysis of ...
 Pharmacy Choice1 month ago
DataMonitor HealthCare

EASD 2016: Renal benefit seen with Victoza in LEADER 3 unlikely to lead to label expansion

Additional data from Victoza's (liraglutide; Novo Nordisk) LEADER 3 cardiovascular outcomes trial in type 2 diabetes were presented on 15 September 2016 at the 52nd Annual Meeting of the European Association for the Study of Diabetes (EASD 2016).
 DataMonitor HealthCare1 week ago More LEADER: Liraglutide Delays Progression of Renal Events  Diabetes Care1 week ago
Times of India

Department of Dietetics, PGI celebrating Nutrition Week

CHANDIGARH: The Department of Dietetics, PGI is celebrating Nutrition Week (1-7th September) by organizing a one-day Continuing Nutrition Education (CNE) programme on 'Beat diabetes and its complications' under the aegis of Indian Dietetic ...
 Times of India3 weeks ago
Minyanville

Baxter and Satellite Healthcare Partner to Bring Innovative Dialysis Care to More Patients

DEERFIELD, Ill.--( BUSINESS WIRE )--Baxter International Inc. (NYSE: BAX), a global leader in renal care, and Satellite Healthcare, a leading, national not-for-profit and the sixth largest provider of patient-centered dialysis and kidney disease ...
 Business Wire1 month ago Baxter International And Partner To Bring Innovative Dialysis Care To More Patients  BioSpace1 month ago Baxter, Satellite Healthcare Partner To Bring Dialysis Care To More Patients  Quotenet.com1 month ago BAXTER INTERNATIONAL : and Satellite Healthcare Partner to Bring Innovative Dialysis Care to More Patients  4 Traders1 month ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less